Hsbc Holdings PLC Crinetics Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 210,821 shares of CRNX stock, worth $8.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210,821

Previous 7,197 2829.29%

Holding current value

$8.73 Million

Previous $206,000 4162.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$26.85 - $45.91 $5.47 Million - $9.35 Million	203,624 Added 2829.29%	210,821 $8.78 Million
Q2 2025 Aug 13, 2025	SELL	$25.56 - $33.76 $160,823 - $212,417	-6,292 Reduced 46.65%	7,197 $206,000
Q1 2025 May 14, 2025	BUY	$32.3 - $53.15 $30,265 - $49,801	937 Added 7.46%	13,489 $452,000
Q4 2024 Feb 14, 2025	BUY	$50.66 - $60.69 $242,560 - $290,583	4,788 Added 61.67%	12,552 $641,000
Q3 2024 Nov 14, 2024	SELL	$43.83 - $54.98 $139,554 - $175,056	-3,184 Reduced 29.08%	7,764 $396,000
Q2 2024 Aug 12, 2024	BUY	$42.12 - $51.91 $171,512 - $211,377	4,072 Added 59.22%	10,948 $490,000
Q1 2024 May 15, 2024	BUY	$34.76 - $46.81 $239,009 - $321,865	6,876 New	6,876 $321,000
Q2 2023 Aug 11, 2023	BUY	$15.73 - $23.6 $193,903 - $290,917	12,327 New	12,327 $222,000
Q1 2021 May 14, 2021	SELL	$13.3 - $17.55 $237,644 - $313,583	-17,868 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$12.08 - $17.46 $21,635 - $31,270	1,791 Added 11.14%	17,868 $252,000
Q3 2020 Nov 12, 2020	BUY	$13.62 - $17.66 $62,624 - $81,200	4,598 Added 40.06%	16,077 $249,000
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $149,686 - $266,657	11,479 New	11,479 $201,000
Q4 2019 Feb 14, 2020	SELL	$15.24 - $25.09 $185,882 - $306,022	-12,197 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.91 - $25.01 $181,857 - $305,046	12,197 New	12,197 $183,000

Others Institutions Holding CRNX

# of Institutions

245

Shares Held

91.1M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.23B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Crinetics Pharmaceuticals, Inc. Transaction History